425: Strive CEO Comments on Semler Scientific Merger

Strive CEO Matthew Cole posted on X.com regarding the proposed business combination with Semler Scientific, Inc., accompanied by a cautionary statement.

Summary

• The filing is a communication posted on X.com by Matthew Cole, CEO of Strive, Inc., on September 22, 2025, concerning Strive's proposed business combination with Semler Scientific, Inc.
• It includes a cautionary statement regarding forward-looking statements related to the proposed transaction, outlining inherent risks and uncertainties.
• The document emphasizes that forward-looking statements are based on assumptions and actual results could differ materially due to various factors.
• It provides information on where to find additional details about the proposed transaction, including Strive's Registration Statement on Form S-4 and Semler Scientific's proxy statement.
• The filing clarifies that it does not constitute an offer to sell or a solicitation of an offer to buy securities or a solicitation of any vote of approval.

Sentiment

Score: 5

Explanation: The filing is neutral in tone, primarily a legal disclosure about a proposed merger, outlining necessary cautionary statements and procedural information. It does not present new positive or negative operational results.

Risks

• The occurrence of any event, change, or circumstances that could lead to the termination of the merger agreement between Strive and Semler Scientific.
• The possibility that the proposed transaction does not close when expected or at all due to conditions to closing not being met or satisfied on a timely basis.
• The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
• The anticipated benefits of the proposed transaction, including cost savings and strategic gains, may not be realized when expected or at all.
• Changes in, or problems arising from, the implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
• General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
• The integration of the two companies may be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Potential adverse reactions from Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing.
• Other factors that may affect future results of Strive, Semler Scientific, or the combined company, including unknown or unpredictable factors.

Future Outlook

The filing includes forward-looking statements regarding the outlook and expectations of Strive and Semler Scientific concerning the proposed transaction, including anticipated strategic and financial benefits, the timing of the closing, and the ability to successfully integrate the combined businesses. These statements are subject to significant risks and uncertainties.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that the combined entity may be pursuing or integrating digital asset strategies, aligning with a growing trend among some companies to incorporate cryptocurrencies into their corporate treasury management or business models.

Legal Proceedings

• The filing mentions the risk of legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company, but does not detail any current proceedings.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock in connection with the proposed transaction.
• Semler Scientific stockholders will be asked to approve the proposed transaction, requiring their review of the Information Statement/Proxy Statement/Prospectus.
• Customers of both Strive and Semler Scientific may have adverse reactions to the proposed transaction.
• Employee relationships at both companies could change as a result of the announcement or completion of the proposed transaction.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register the Class A common stock to be issued in connection with the proposed transaction.
• The Registration Statement will include an information statement of Strive, a proxy statement of Semler Scientific, and a prospectus of Strive.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to the stockholders of Semler Scientific to seek their approval of the proposed transaction.
• Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, along with other relevant SEC documents.

Key Dates

Recommendation

This filing is a standard legal disclosure related to a proposed business combination, primarily serving as a cautionary statement regarding forward-looking information and outlining where to find additional details. It does not contain new operational or financial results that would alter an investment thesis based on the companies' fundamentals. A 'hold' recommendation is appropriate as investors await the full Registration Statement on Form S-4 and the Information Statement/Proxy Statement/Prospectus to make an informed decision on the merger's merits.

Keywords

Strive Inc., Semler Scientific Inc., Merger, Acquisition, Business Combination, SEC Filing, Form 425, Forward-Looking Statements, Risk Factors, Bitcoin Treasury Strategy